Series A - MEDIVIS

Series A - MEDIVIS

Investment Firm

Overview

Medivis is a medical technology company leveraging augmented reality and artificial intelligence to advance surgical care.

Announced Date

Jun 13, 2023

Funding Type

Series A

Highlights

Location

New York, New York, United States, North America

Social

Investor Lead

Thrive Capital

Thrive Capital

Thrive Capital is a early_stage_venture and late_stage_venture and seed firm.

Participant Investors

9

Investor Name
Participant InvestorHugo Barra
Participant InvestorRobert Iger
Participant InvestorMayo Clinic
Participant InvestorThrive Capital
Participant InvestorInitialized Capital

Round Details and Background

MEDIVIS raised $20000000 on 2023-06-13 in Series A

Medivis is a medical technology company leveraging augmented reality and artificial intelligence to advance surgical care.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Feb 12, 2019
Seed Round - MEDIVIS
2-2.3M
Feb 07, 2020
Seed Round - MEDIVIS
3-2.7M
Jun 13, 2023
Series A - MEDIVIS
9-20.0M

Recent Activity

There is no recent news or activity for this profile.